XML 18 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Assets and Liabilities (USD $)
Mar. 31, 2014
Dec. 31, 2013
ASSETS    
Investment in palladium (cost: March 31, 2014: $417,667; December 31, 2013: $463,598) $ 500,836,000 [1],[2] $ 510,475,000
Investment in palladium, lower of cost or market value (cost: March 31, 2014: $417,667; December 31, 2013: $463,598)   463,598,000 [2],[3]
Total assets 500,836,000 [1] 463,598,000 [3]
LIABILITIES    
Fees payable to Sponsor 254,423 260,849
Total liabilities 255,000 [1] 261,000 [3]
NET ASSETS 500,581,000 [1] 463,337,000 [3]
ANALYSIS OF NET ASSETS    
Redeemable Shares at redemption value to investors 500,581,000 [1],[4] 510,214,000 [3],[4]
Shareholders’ deficit 0 [1] (46,877,000) [3]
Total redeemable shares at redemption value to investors (net asset value) $ 500,581,000 [1],[4] $ 463,337,000 [1],[3],[4]
[1] Effective January 1, 2014, the Trust has adopted the provisions of Topic 946, Investment Companies, and follows specialized accounting. Refer to Note 2.1 for additional information.
[2] At March 31, 2014, the investment in palladium is recorded at fair value. At December 31, 2013, the investment in palladium was recorded at the lower of cost or market value. Refer to note 2.1 for a breakdown of cost and fair value of the investment in palladium.
[3] Derived from audited Statement of Financial Condition as of December 31, 2013. The amounts are those previously reported under non investment company accounting. Refer to Note 2.1 for additional information.
[4] Authorized share capital is unlimited with no par value per Share. Shares issued and outstanding at March 31, 2014 were 6,600,000 and at December 31, 2013 were 7,350,000. Net asset value per Share at March 31, 2014 and December 31, 2013 was $75.85 and $69.42, respectively.